衞光生物(002880.SZ):決定將鐘山漿站搬遷進行重建
格隆匯 7 月 30日丨衞光生物(002880.SZ)公佈,公司於2020年7月30日召開第二屆董事會第三十二次會議、第二屆監事會第二十二次會議審議通過《關於變更部分募集資金用途的議案》,由於原募投項目“單採血漿站改擴建項目”下的鐘山漿站項目所在地鐘山縣鐘山鎮龜石南路31號被政府徵地,經公司審慎研究,擬對首次公開發行股票部分募集資金投資項目進行變更,決定將鐘山漿站搬遷至鐘山縣鐘山鎮快速環道程石村段東西側進行重建。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.